ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36844
-0.06%
Bitcoin
64,221.79
0.35%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Myriad Genetics Inc (MYGN)

  7. Myriad Genetics Inc (MYGN) News

MYGN Myriad Genetics Inc

19.43
0.21 (1.09%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Myriad Genetics Inc MYGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.21 1.09% 19.43 16:58:41
Open Price Low Price High Price Close Price Previous Close
19.85 19.40 20.09 19.47 19.22
more quote information »

Recent News

Date Time Source Heading
4/30/202415:05GLOBEMyriad Genetics to Release First Quarter 2024 Financial..
4/17/202407:00GLOBENearly Half of Americans Say They’ve Lost Time in Their..
4/16/202408:15GLOBENew Myriad Genetics Study Published in Prenatal Diagnosis..
4/09/202407:00GLOBEMyriad Genetics Research Shows Reduction in Hospitalizations..
3/21/202420:40GLOBEMyriad Genetics Announces Foundational Patent Granted for..
3/20/202415:05GLOBEMyriad Genetics Announces Patent Granted for SneakPeek® Snap..
3/04/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202407:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/202415:05EDGAR2Form 8-K - Current report
2/27/202415:05GLOBEMyriad Genetics Reports Strong Fourth Quarter and Full-Year..
2/27/202408:15GLOBEMyriad Genetics and National Cancer Center Hospital East in..
2/26/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:05GLOBEMyriad Genetics to Release Fourth Quarter and Full Year 2023..
2/15/202415:05GLOBEMyriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as..
2/14/202415:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202407:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202409:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202408:25GLOBEMyriad Genetics Completes Acquisition of Precise Tumor,..
1/31/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202416:00GLOBEMyriad Genetics Names George Daneker Jr., MD, as President..
1/29/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202415:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/23/202415:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/22/202413:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/18/202417:10GLOBEMyriad Genetics to Acquire Precise Tumor, Precise Liquid and..
1/16/202408:00EDGAR2Form 8-K - Current report
1/09/202415:05GLOBEMyriad Genetics Applauds New Germline Testing Guideline for..
1/03/202415:05GLOBEMyriad Genetics to Present at 42nd Annual J.P. Morgan..
1/02/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202307:30EDGAR2Form 8-K - Current report
12/21/202307:30GLOBEMyriad Genetics Chief Financial Officer Bryan Riggsbee..
12/20/202307:00GLOBEMyriad Genetics Establishes Comprehensive Pan-Cancer..
12/11/202317:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202317:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/05/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202315:05GLOBEMyriad Genetics Celebrates One Million SneakPeek® Results..
11/16/202315:05GLOBEMyriad Genetics and Personalis Partner to Market..
11/13/202315:31EDGAR2Form 8-K - Current report
11/13/202305:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/09/202306:00GLOBEMyriad Genetics to Participate in Stephens Annual Investment..
11/08/202320:20GLOBEMyriad Genetics Announces Pricing of Upsized Offering of..
11/08/202320:16EDGAR2Form 8-K - Current report
11/08/202315:10GLOBEMyriad Genetics Announces Proposed Offering of $100 Million..
11/08/202315:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/08/202315:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/07/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202315:05EDGAR2Form 8-K - Current report
11/06/202315:05GLOBEMyriad Genetics Reports Third Quarter 2023 Financial..
11/03/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
MYGN
Myriad Genetics
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved